{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T07:08:11Z","timestamp":1784531291987,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["COBB23B0"],"award-info":[{"award-number":["COBB23B0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.eprac.2026.02.007","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:06:07Z","timestamp":1770883567000},"page":"779-787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Endocrine Care During Transition in Emerging Adults With Cystic Fibrosis: A Single Center Retrospective Study"],"prefix":"10.1016","volume":"32","author":[{"given":"Crystal","family":"Cobb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Feeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Nilo G Binongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanicia","family":"Daley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel W.","family":"Linnemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene","family":"Stecenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin","family":"Tangpricha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eprac.2026.02.007_bib2","series-title":"Cystic Fibrosis Foundation Patient Registry 2023 Annual Data Report Bethesda","year":"2024"},{"issue":"4","key":"10.1016\/j.eprac.2026.02.007_bib3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.pcl.2016.04.009","article-title":"Endocrine disorders in cystic fibrosis","volume":"63","author":"Blackman","year":"2016","journal-title":"Pediatr Clin North Am"},{"issue":"6","key":"10.1016\/j.eprac.2026.02.007_bib4","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1055\/s-0039-1697917","article-title":"Endocrine complications of cystic fibrosis: a multisystem disease of the endocrine organs","volume":"40","author":"Ode","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.eprac.2026.02.007_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2265.2012.04484.x","article-title":"The impact of dysglycaemia on bone mineral accrual in young people with cystic fibrosis","volume":"78","author":"Rana","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.eprac.2026.02.007_bib6","article-title":"Cystic Fibrosis Related Diabetes (CFRD) prognosis","volume":"26","author":"Sandouk","year":"2021","journal-title":"J Clin Transl Endocrinol"},{"issue":"11","key":"10.1016\/j.eprac.2026.02.007_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10666","article-title":"Prevalence and risk factors for low bone mineral density in adults with cystic fibrosis","volume":"6","author":"Boyle","year":"2022","journal-title":"JBMR Plus"},{"issue":"1","key":"10.1016\/j.eprac.2026.02.007_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jbspin.2011.05.009","article-title":"Bone loss in adults with cystic fibrosis: prevalence, associated factors, and usefulness of biological markers","volume":"79","author":"Legroux-G\u00e9rot","year":"2012","journal-title":"Joint Bone Spine"},{"issue":"3","key":"10.1016\/j.eprac.2026.02.007_bib9","first-page":"283","article-title":"Bone involvement in young adults with cystic fibrosis - a Portuguese cohort","volume":"46","author":"Garcia","year":"2021","journal-title":"Acta Reumatol Port"},{"issue":"6","key":"10.1016\/j.eprac.2026.02.007_bib10","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00198-019-04893-z","article-title":"Bone involvement in young adults with cystic fibrosis awaiting lung transplantation for end-stage respiratory failure","volume":"30","author":"Cairoli","year":"2019","journal-title":"Osteoporos Int"},{"issue":"12","key":"10.1016\/j.eprac.2026.02.007_bib11","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1093\/jbmr\/zjae139","article-title":"Longitudinal changes in BMD in adults with cystic fibrosis","volume":"39","author":"Jad","year":"2024","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.eprac.2026.02.007_bib12","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1210\/jc.2004-1629","article-title":"Guide to bone health and disease in cystic fibrosis","volume":"90","author":"Aris","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.eprac.2026.02.007_bib13","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical Care Guidelines for Cystic Fibrosis\u2013Related diabetes: a position statement of the American Diabetes Association and a Clinical Practice Guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.eprac.2026.02.007_bib14","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-2587","article-title":"Supporting the health care transition from adolescence to adulthood in the medical home","volume":"142","author":"White","year":"2018","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.eprac.2026.02.007_bib15","doi-asserted-by":"crossref","first-page":"946","DOI":"10.4158\/EP13109.OR","article-title":"Health care transition in young adults with type 1 diabetes: barriers to timely establishment of adult diabetes care","volume":"19","author":"Garvey","year":"2013","journal-title":"Endocr Pract"},{"issue":"6","key":"10.1016\/j.eprac.2026.02.007_bib16","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/adc.2010.202473","article-title":"Improving the transition between paediatric and adult healthcare: a systematic review","volume":"96","author":"Crowley","year":"2011","journal-title":"Arch Dis Child"},{"issue":"11","key":"10.1016\/j.eprac.2026.02.007_bib17","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.2337\/dc11-1723","volume":"34","author":"Peters","year":"2011","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.eprac.2026.02.007_bib18","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2337\/dc15-0078","article-title":"Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D exchange clinic registry","volume":"38","author":"Miller","year":"2015","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.eprac.2026.02.007_bib19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2337\/dc21-0507","article-title":"Trends in glycemic control among youth and young adults with diabetes: the SEARCH for diabetes in youth study","volume":"45","author":"Malik","year":"2022","journal-title":"Diabetes Care"},{"issue":"Issue 5","key":"10.1016\/j.eprac.2026.02.007_bib20","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jpeds.2004.12.039","article-title":"Epidemiology of cystic fibrosis-related diabetes","volume":"146","author":"Marshall","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.eprac.2026.02.007_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2023.113812","article-title":"Predictors of transition outcomes in cystic fibrosis: analysis of national patient registry and CF RISE (Responsibility. Independence. Self-care. Education) data","volume":"265","author":"Melton","year":"2024","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.eprac.2026.02.007_bib22","first-page":"47","article-title":"Severe bone demineralisation is associated with higher mortality in children with cystic fibrosis","volume":"102","author":"O'Reilly","year":"2009","journal-title":"Ir Med J"},{"issue":"12","key":"10.1016\/j.eprac.2026.02.007_bib23","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1002\/ppul.23894","article-title":"Bone mineral density is related to lung function outcomes in young people with cystic fibrosis-A retrospective study","volume":"52","author":"Smith","year":"2017","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.eprac.2026.02.007_bib24","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.bone.2004.05.021","article-title":"Severe osteopenia in CFTR-null mice","volume":"35","author":"Dif","year":"2004","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.eprac.2026.02.007_bib25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1183\/09031936.04.00050204","article-title":"Reduced bone density in cystic fibrosis: DeltaF508 mutation is an independent risk factor","volume":"25","author":"King","year":"2005","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.eprac.2026.02.007_bib26","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1164\/rccm.201312-2144LE","article-title":"Cystic fibrosis and bone disease: defective osteoblast maturation with the F508del mutation in cystic fibrosis transmembrane conductance regulator","volume":"189","author":"Velard","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.eprac.2026.02.007_bib27","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2478\/ams-2013-0011","article-title":"Bone turnover markers, osteoprotegerin and RANKL cytokines in children with cystic fibrosis","volume":"58","author":"Ambroszkiewicz","year":"2013","journal-title":"Adv Med Sci"},{"issue":"1","key":"10.1016\/j.eprac.2026.02.007_bib28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jcf.2022.08.011","article-title":"Evaluation of an association between RANKL and OPG with bone disease in people with cystic fibrosis","volume":"22","author":"Abid","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.eprac.2026.02.007_bib29","doi-asserted-by":"crossref","DOI":"10.1177\/20420188251328210","article-title":"Cystic fibrosis-related bone disease: an update on screening, diagnosis, and treatment","volume":"16","author":"Cobb","year":"2025","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2026.02.007_bib30","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bone.2004.05.009","article-title":"Prevalence and correlates of vertebral fractures in adults with cystic fibrosis","volume":"35","author":"Rossini","year":"2004","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.eprac.2026.02.007_bib31","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1378\/chest.130.2.539","article-title":"Prevalence of vertebral fractures in adults with cystic fibrosis and their relationship to bone mineral density","volume":"130","author":"Stephenson","year":"2006","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.eprac.2026.02.007_bib32","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.eprac.2025.04.011","article-title":"Menopause in cystic fibrosis: special considerations for bone health, menopausal symptoms, and treatment","volume":"31","author":"Haroon","year":"2025","journal-title":"Endocr Pract"},{"issue":"2","key":"10.1016\/j.eprac.2026.02.007_bib33","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00774-014-0572-z","article-title":"Factors associated with low bone mineral density in patients with cystic fibrosis","volume":"33","author":"Sheikh","year":"2015","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.eprac.2026.02.007_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2023.116835","article-title":"Changes in bone turnover after high-dose vitamin D supplementation during acute pulmonary exacerbation in cystic fibrosis","volume":"174","author":"Wu","year":"2023","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.eprac.2026.02.007_bib35","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02029-2022","article-title":"Long-term safety and efficacy of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from a 192-week open-label extension study","volume":"62","author":"Daines","year":"2023","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.eprac.2026.02.007_bib36","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1513\/AnnalsATS.202312-1065OC","article-title":"Multisystemic effects of elexacaftor-tezacaftor-ivacaftor in adults with cystic fibrosis and advanced lung disease","volume":"21","author":"Burgel","year":"2024","journal-title":"Ann Am Thorac Soc"},{"issue":"4","key":"10.1016\/j.eprac.2026.02.007_bib37","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jcf.2024.02.005","article-title":"Vitamin D status and variable responses to supplements depend in part on genetic factors in adults with cystic fibrosis","volume":"23","author":"Braun","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.eprac.2026.02.007_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2025.106810","article-title":"Vitamin D status in young adults with cystic fibrosis on highly effective CFTR modulator therapy","volume":"253","author":"Cobb","year":"2025","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"10.1016\/j.eprac.2026.02.007_bib39","doi-asserted-by":"crossref","first-page":"e1248","DOI":"10.1210\/clinem\/dgaa890","article-title":"The effects of ivacaftor on bone density and microarchitecture in children and adults with cystic fibrosis","volume":"106","author":"Putman","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.eprac.2026.02.007_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/ppul.71280","article-title":"Elexacaftor\/Tezacaftor\/Ivacaftor effect on bone density and body composition: a retrospective analysis","volume":"60","author":"Trost","year":"2025","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.eprac.2026.02.007_bib41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pedn.2021.06.004","article-title":"Formal vs. informal transition in adolescents with cystic fibrosis: a retrospective comparison of outcomes","volume":"62","author":"Middour-Oxler","year":"2022","journal-title":"J Pediatr Nurs"},{"issue":"1","key":"10.1016\/j.eprac.2026.02.007_bib42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ecl.2023.09.003","article-title":"Incorporating the six core elements of health care transition in type 1 diabetes care for emerging adults","volume":"53","author":"Malik","year":"2024","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"10.1016\/j.eprac.2026.02.007_bib43","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1186\/s12913-023-09644-9","article-title":"Transition models of care for type 1 diabetes: a systematic review","volume":"23","author":"Zurynski","year":"2023","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"10.1016\/j.eprac.2026.02.007_bib44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jadohealth.2016.10.002","article-title":"Components of interventions that improve transitions to adult care for adolescents with type 1 diabetes","volume":"60","author":"Schultz","year":"2017","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.eprac.2026.02.007_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1137976","article-title":"Transition of young adults with metabolic bone diseases to adult care","volume":"14","author":"Ross","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.eprac.2026.02.007_bib46","article-title":"Automatic referrals within a cystic fibrosis multidisciplinary clinic improve patient evaluation and management","volume":"24","author":"Darukhanavala","year":"2021","journal-title":"J Clin Transl Endocrinol"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26007846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26007846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:57:34Z","timestamp":1784530654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X26007846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1530891X26007846"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2026.02.007","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocrine Care During Transition in Emerging Adults With Cystic Fibrosis: A Single Center Retrospective Study","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2026.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}